PROTEOMICS INT LAB ORDINARY (PIQ) Short Interest
PROTEOMICS INT LAB ORDINARY (ASX:PIQ) had 0.35% of shares reported as short positions as of 26 June 2026, representing 584,425 shares. PROTEOMICS INT LAB ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
PIQ
Proteomics International Laboratories
Proteomics International Laboratories Ltd (ASX:PIQ) is a medical technology company specializing in predictive diagnostics and bio-analytical services. They focus on proteomics, the industrial-scale study of protein structure and function, to develop novel diagnostic tests like PromarkerD, PromarkerEndo, and PromarkerEso, aiming to bring these to global markets.